Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.42 |
| ▸ | LPL | P06858 | 13/20 | 0.42 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22159669 | 0.92 | LIPG (0.42) | LIPGLPLIRAK4EGFRP4HB | |
| SCHEMBL23406391 | 0.87 | LIPG (0.41) | LIPGLPLIRAK4EGFRCA1 | |
| SCHEMBL29906160 | 0.86 | LIPG (0.42) | LIPGLPLIRAK4P4HBCA1 | |
| SCHEMBL23406345 | 0.86 | LIPG (0.42) | LIPGLPLIRAK4P4HBCA1 | |
| SCHEMBL32675823 | 0.83 | LIPG (0.42) | LIPGLPLIRAK4EGFR | |
| SCHEMBL31730277 | 0.83 | LIPG (0.55) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL22181581 | 0.81 | LPL (0.34) | LIPGLPL | |
| SCHEMBL22159670 | 0.78 | LPL (0.34) | LIPGLPL | |
| SCHEMBL31676639 | 0.78 | LPL (0.34) | LIPGLPL | |
| SCHEMBL47074 | 0.78 | LPL (0.53) | LIPGLPLIRAK4P4HBROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11600790-B2 | Polycyclic aromatic compound for organic electroluminescent device | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-07 | — | — | US | disclosed |
| US-11600790-B2 | Polycyclic aromatic compound for organic electroluminescent device | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-07 | — | — | US | disclosed |
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-02-15 | — | — | US | disclosed |
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-02-15 | — | — | US | disclosed |
| US-20210167288-A1 | POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2021-06-03 | — | — | US | disclosed |
| US-20210167288-A1 | POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2021-06-03 | — | — | US | disclosed |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-07-02 | — | — | US | disclosed |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11248009-B2 | Polycyclic aromatic compound, material for an organic device, organic electroluminescent element, display apparatus and lighting apparatus | TYR, AOC2, AOC1 | LIPG 1492/4885LPL 1062/4885IRAK4 1475/4885 |
| US-20210167288-A1 | POLYCYCLIC AROMATIC COMPOUND | ARNT, TYR, AHR | LIPG 3943/4885LPL 3842/4885IRAK4 2430/4885 |
| US-11600790-B2 | Polycyclic aromatic compound for organic electroluminescent device | AOC2, TYR, BMI1 | LIPG 2974/4885LPL 3065/4885IRAK4 2317/4885 |
| US-20200207787-A1 | POLYCYCLIC AROMATIC COMPOUND, MATERIAL FOR AN ORGANIC DEVICE, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY APPARATUS AND LIGHTING APPARATUS | TYR, AOC2, AOC1 | LIPG 1492/4885LPL 1062/4885IRAK4 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.